In this direction, a skin equivalent (encompassing both epidermis and dermis) for SPINK5-sEDD (Netherton syndrome) was previously designed, to test the role of KLK7 and KLK5 gene silencing [31], or their chemical inhibition [32] in reversing the disease phenotype. This evidence concerns the gene SPINK5 and Netherton syndrome.